| abstract |
The present invention relates to compounds of formula (I) (see formula I) wherein U, V, W, A1, A2, A3, A4, A5, A6, m and n are as defined in the description and claims and pharmaceutically acceptable salts and/or pharmaceutically acceptable esters thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyper-proliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |